Literature DB >> 4427648

Massachusetts Department of Public Health. Cost-benefit analysis of newborn screening for metabolic disorders.

.   

Abstract

Entities:  

Mesh：

Year:  1974        PMID： 4427648     DOI： 10.1056/NEJM197412262912614

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  3 in total

1.  Secondary analysis of economic data: a review of cost-benefit studies of neonatal screening for phenylketonuria.

Authors:  J Lord; M J Thomason; P Littlejohns; R A Chalmers; M D Bain; G M Addison; A H Wilcox; C A Seymour
Journal:  J Epidemiol Community Health       Date:  1999-03       Impact factor: 3.710

2.  Showing Value in Newborn Screening: Challenges in Quantifying the Effectiveness and Cost-Effectiveness of Early Detection of Phenylketonuria and Cystic Fibrosis.

Authors:  Scott D Grosse
Journal:  Healthcare (Basel)       Date:  2015-11-11

3.  Newborn Screening and Treatment of Phenylketonuria: Projected Health Outcomes and Cost-Effectiveness.

Authors:  Huey-Fen Chen; Angela M Rose; Susan Waisbren; Ayesha Ahmad; Lisa A Prosser
Journal:  Children (Basel)       Date:  2021-05-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.